
1. transplant proc. 2009 jan-feb;41(1):246-9. doi:
10.1016/j.transproceed.2008.10.056.

efficacy interferon beta combined cyclosporine induction intensified 
therapy retreatment chronic hepatitis c.

inoue k(1), watanabe t, yamada m, yoshikumi h, ogawa o, yoshiba m.

author information: 
(1)division gastroenterology, showa university fujigaoka hospital, yokohama,
japan. kazuaki-inoue@showa-university-fujigaoka.gr.jp

objective: hepatitis c virus (hcv) infection major burden liver
transplantation. effective treatment patients, therefore
management challenging. cyclophilins essential host factors hcv
replication. reported herein efficacy divided administration of
interferon (ifn) beta plus cyclosporine chronic hepatitis c patients who
failed pegylated (peg)-ifn ifn combined ribavirin treatment.
patients methods: prospectively enrolled 59 patients (median age, 63
years) genotype 1b failed respond combinations ifn plus
ribavirin peg-ifn plus ribavirin. treatment involved induction,
intensified, maintenance therapies. induction therapy prescribed
intravenous 1 mu ifn beta every 4 hours first 3 days, 1.5 mu ifn beta
every 6 hours next 4 days, 2 mu ifn beta every 8 hours 3
weeks. intensified therapy induction therapy shortened 2 weeks.
the maintenance therapy involved peg-ifn alpha 2b ribavirin. cyclosporine was
given 4 times daily induction intensified therapies. ribavirin was
given twice daily maintenance phase.
results: end treatment sustained virological response rates the
present study 73% (43/59) 59% (35/59), respectively. relapse rate
was 19% (8/43). sixteen percent patients (3/19) nonresponders. all
adverse effects reversible. treatment protocol well tolerated.
conclusion: protocol effective patients failed
previous combination therapies.

doi: 10.1016/j.transproceed.2008.10.056 
pmid: 19249526  [indexed medline]

